Studies related to Allergies and Rosmarinic Acid

Extract Of Perilla Frutescens Enriched For Rosmarinic Acid, A Polyphenolic Phytochemical, Inhibits Seasonal Allergic Rhinoconjunctivitis In Humans

Effect Decrease
Trial Design Double blind
Trial Length 2-4 Weeks
Number of Subjects 29
Sex Both Genders
Age Range 18-29, 30-44
Notes for this study:
50mg and 200mg Rosmarinic acid were, via self-report in a blinded manner, significantly better than placebo at suppressing allergic symptoms during allergy season over 21 days. The count of immune cells in the nasal mucus decreased by day 3, but no significant difference was seen in pro-inflammatory markers